Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Joseph A. De Leo

90 indexed publications match this author name.

ORCID
0000-0002-1793-119X
OpenAlex
https://openalex.org/A5043460196

Author watchlist

Create a confirmed email alert for new publications matching this author.

Publication history

Participant experiences and recommendations for psychedelic clinical trials and future treatment delivery: a qualitative study with experts by experience from the Psychedelic Participant Advocacy NetworkFrontiers in Psychiatry · 2026-10-14Neural correlates and behavioral outcomes of aesthetic chills and their prosthetic augmentationPsyArXiv · 2026-09-13“Am I a candidate for magic mushrooms?” A mystery shopper study of Oregon psilocybin service centersHealth Affairs Scholar · 2026-08-27Psychedelics align brain activity with context.Nature · 2026-08-19Defining 'psychedelic'.Journal of psychopharmacology (Oxford, England) · 2026-08-17Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic CircuitsHuman Brain Mapping · 2026-07-01PsiConnect: Multimodal Neuroimaging of Context-Dependent Brain and Behaviour Dynamics under PsilocybinScientific Data · 2026-05-21Human brain changes after first psilocybin useNature Communications · 2026-05-05Effects of psychedelic use on authoritarian attitudes revisited.Journal of psychopharmacology (Oxford, England) · 2026-05-01Psilocybin and human longevitynpj Aging · 2026-04-03An international mega-analysis of psychedelic drug effects on brain circuit function.Nature medicine · 2026-04-01Psychoactive mushroom edibles: trends and toxicities reported to the United States National Poison Data System®, 2023-2024.Clinical toxicology (Philadelphia, Pa.) · 2026-03-01Sex-dependent effects of psychedelics: review of evidence from rodent models.Frontiers in psychiatry · 2026-01-01COMPARATIVE EFFICACY AND ACCEPTABILITY OF PSILOCYBIN-KETAMINE AND TYPICAL ANTIDEPRESSANTS FOR MAJOR DEPRESSIVE DISORDER MANAGEMENT: A NETWORK META-ANALYSISThe Study of Phenomena Related to Health · 2026-01-01A novel psychedelic 5-HT receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteer.Journal of psychopharmacology (Oxford, England) · 2026-01-01Effects of LSD and Psilocybin on Heart Rate in Patients Receiving Psychedelic Treatment for Depressive and Anxiety Disorders: A Retrospective Observational StudyPsychology International · 2025-12-19The polypharmacology of psychedelics reveals multiple targets for potential therapeutics.Neuron · 2025-10-01Psilocybin-Assisted Psychotherapy for Chronic Somatoform Pain Disorder: A Case ReportPsychoactives · 2025-09-01Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises.Molecular psychiatry · 2025-07-01Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat Settings.Brain and behavior · 2025-07-01Exploring psilocybin's role in mental health and palliative medicine: a path to improved well-being.Expert opinion on emerging drugs · 2025-06-01The Therapeutic Potential of Psychedelics in Treating Substance Use Disorders: A Review of Clinical Trials.Medicina (Kaunas, Lithuania) · 2025-02-06BEHAVIORAL PHENOTYPING AND METABOLOMIC COMPARISON OF CHEMICALLY SYNTHESIZED PSILOCYBIN AND PSYCHEDELIC MUSHROOM EXTRACT IN A ZEBRAFISH DEPRESSION MODELThe international journal of neuropsychopharmacology · 2025-02-01Psilocybin Mushrooms and Public Health in Brazil: Insights from a Retrospective Analysis of Adverse Events and Their Implications for Regulatory Discussions.International journal of medicinal mushrooms · 2025-01-01Enhanced meaning in life following psychedelic use: converging evidence from controlled and naturalistic studies.Frontiers in psychology · 2025-01-01Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in a psilocybin retreat.Frontiers in psychiatry · 2025-01-01Moving psychedelic-assisted therapies from promising research into routine clinical practice: Lessons from the field of implementation science.Translational behavioral medicine · 2024-11-25Neural Mechanisms of Resting-State Networks and the Amygdala Underlying the Cognitive and Emotional Effects of Psilocybin.Biological psychiatry · 2024-07-01Effect of chemically synthesized psilocybin and psychedelic mushroom extract on molecular and metabolic profiles in mouse brain.Molecular psychiatry · 2024-07-01Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin.Med (New York, N.Y.) · 2024-03-08Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive DisorderInternational Journal of Mental Health and Addiction · 2024-03-07Antidepressant- and anxiolytic-like activities and acute toxicity evaluation of the Psilocybe cubensis mushroom in experimental models in mice.Journal of ethnopharmacology · 2024-02-10Psychedelics and sexual functioning: a mixed-methods study.Scientific reports · 2024-02-07Psychotherapy in Psychedelic Treatment: Safe, Evidence-Based, and NecessaryAmerican Journal of Psychiatry · 2024-01-01Misinterpretations and Omissions: A Critical Response to Goodwin and Colleagues' Commentary on Psilocybin-Assisted Therapy.The American journal of psychiatry · 2024-01-01Is Poorly Assisted Psilocybin Treatment an Increasing Risk?The American journal of psychiatry · 2024-01-01Psilocybin Without Psychotherapy: A Cart Without a Horse?The American journal of psychiatry · 2024-01-01The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.Current neuropharmacology · 2024-01-01Domestication through clandestine cultivation constrained genetic diversity in magic mushrooms relative to naturalized populations.Current biology: CB · 2023-12-04Expectancies for Subjective and Antidepressant Effects in Psilocybin UsersJournal of Humanistic Psychology · 2023-09-22In vivo mapping of pharmacologically induced functional reorganization onto the human brain's neurotransmitter landscape.Science advances · 2023-06-16Antidepressant Effects of Psilocybin in the Absence of Psychedelic Effects.The American journal of psychiatry · 2023-05-01Canalization and plasticity in psychopathology.Neuropharmacology · 2023-03-15Therapeutic potential of psilocybin: a promising agent in treating major depressive disorderAIDASCO Reviews · 2023-01-17How Important Is a Guide Who Has Taken Psilocybin in Psilocybin-Assisted Therapy for Depression?Journal of psychoactive drugs · 2023-01-01Body mass index (BMI) does not predict responses to psilocybin.Journal of psychopharmacology (Oxford, England) · 2023-01-01Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression.Journal of psychopharmacology (Oxford, England) · 2023-01-01Scoping Review of Experiential Measures from Psychedelic Research and Clinical Trials.Journal of psychoactive drugs · 2023-01-01The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world.Psychopharmacology · 2022-11-01Receptor-informed network control theory links LSD and psilocybin to a flattening of the brain's control energy landscape.Nature communications · 2022-10-03Effects of psilocybin versus escitalopram on rumination and thought suppression in depression.BJPsych open · 2022-09-06Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex.NeuroImage · 2022-08-01Increased global integration in the brain after psilocybin therapy for depression.Nature medicine · 2022-04-01Effects of classic psychedelic drugs on turbulent signatures in brain dynamics.Network neuroscience (Cambridge, Mass.) · 2022-01-01Exploring the Credibility of Psilocybin-assisted Therapy and Cognitive-behavioral Therapy for Depression.Journal of psychoactive drugs · 2022-01-01P.0885 The effect of psilocybin therapy for depression on low-frequency brain activity in response to musicEuropean Neuropsychopharmacology · 2021-12-01Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property.Frontiers in pharmacology · 2021-01-01Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression.Journal of psychopharmacology (Oxford, England) · 2020-02-01Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybin.NeuroImage · 2019-10-01Increased use of illicit drugs in a Dutch cluster headache population.Cephalalgia: an international journal of headache · 2019-04-01Psychedelic fungus (Psilocybe sp.) authentication in a case of illegal drug traffic: sporological, molecular analysis and identification of the psychoactive substance.Science & justice: journal of the Forensic Science Society · 2019-01-01Does getting high hurt? Characterization of cases of LSD and psilocybin-containing mushroom exposures to national poison centers between 2000 and 2016.Journal of psychopharmacology (Oxford, England) · 2018-12-01Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression.Neuropharmacology · 2018-11-01Effects of psilocybin therapy on personality structure.Acta psychiatrica Scandinavica · 2018-11-01The hidden therapist: evidence for a central role of music in psychedelic therapy.Psychopharmacology · 2018-02-01Psychedelics, Meditation, and Self-Consciousness.Frontiers in psychology · 2018-01-01Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.Scientific reports · 2017-10-13[Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges].Fortschritte der Neurologie-Psychiatrie · 2017-07-01Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression.Frontiers in pharmacology · 2017-01-01The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms.Journal of psychopharmacology (Oxford, England) · 2016-12-01DNA-based taxonomic identification of basidiospores in hallucinogenic mushrooms cultivated in “grow-kits” seized by the police: LC-UV quali-quantitative determination of psilocybin and psilocinJournal of Pharmaceutical and Biomedical Analysis · 2016-06-01Taxonomic Identification of Hallucinogenic Mushrooms Seized on the Illegal Market Using a DNA-Based Approach and LC/MS-MS Determination of Psilocybin and PsilocinJournal of Analytical & Bioanalytical Techniques · 2015-01-01The challenging experience questionnaire: Characterization of acute adverse reactions to psilocybinDrug and Alcohol Dependence · 2014-12-16The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers.Frontiers in human neuroscience · 2014-01-01Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin.Journal for the scientific study of religion · 2012-12-01[Hallucinogen-induced psychological disorders].Fortschritte der Neurologie-Psychiatrie · 2008-06-01Designer HallucinogensEmergency Medicine News · 2003-12-01Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled study.Psychopharmacology · 1999-02-01Increased activation of indirect semantic associations under psilocybin.Biological psychiatry · 1996-06-15[Psychedelic experiences at the onset of productive episodes of endogenous psychoses].Der Nervenarzt · 1994-03-01Relief of obsessive-compulsive symptoms by LSD and psilocinAmerican Journal of Psychiatry · 1987-09-01ChemInform Abstract: COMPARISON OF SOLUTION CONFORMATIONAL PREFERENCES FOR THE HALLUCINOGENS BUFOTENIN AND PSILOCIN USING 360-MHZ PROTON NMR SPECTROSCOPYChemischer Informationsdienst · 1981-07-14Comparison of solution conformational preferences for the hallucinogens bufotenin and psilocin using 360-MHz proton NMR spectroscopyJournal of Medicinal Chemistry · 1981-02-012,5-dimethoxy-4-methyl-amphetamine (STP): a new hallucinogenic drug.Science (New York, N.Y.) · 1967-11-03Drugs and phantasy: the effects of LSD, psilocybin, and sernyl on college studentsMedical Entomology and Zoology · 1965-01-01CLINICAL SYNDROMES AND BIOCHEMICAL ALTERATIONS FOLLOWING MESCALINE, LYSERGIC ACID DIETHYLAMIDE, PSILOCYBIN AND A COMBINATION OF THE THREE PSYCHOTOMIMETIC DRUGS.Comprehensive psychiatry · 1964-06-01EFFECT OF MESCALINE, LYSERGIC ACID DIETHYLAMIDE AND PSILOCYBIN ON COLOR PERCEPTION.Psychopharmacologia · 1963-08-20Mescaline, lysergic acid diethylamide and psilocybin comparison of clinical syndromes, effects on color perception and biochemical measures.Comprehensive psychiatry · 1962-08-01Controlled sensory input: a note on the technic of drug evaluation with a preliminary report on a comparative study of sernyl, psilocybin, and LSD-25.Comprehensive psychiatry · 1960-12-01Comparison of three psychotropic drugs (psilocybin, JB-329, and IT-290) in volunteer subjects.The Journal of nervous and mental disease · 1960-11-01

Author directory

Robin Carhart-Harris178 publicationsDavid Nutt122 publicationsDavid Erritzøe85 publicationsFranz X. Vollenweider85 publicationsRoland R. Griffiths84 publicationsMatthew W. Johnson71 publicationsKatrin H. Preller64 publicationsFrederick S. Barrett61 publicationsGitte M. Knudsen58 publicationsLeor Roseman55 publicationsJames Rucker49 publicationsAlbert Garcia-Romeu46 publicationsTomáš Páleníček45 publicationsPatrick M. Fisher44 publicationsSandeep M. Nayak43 publicationsDea Siggaard Stenbæk42 publicationsJoshua D. Rosenblat42 publicationsKim P. C. Kuypers41 publicationsNatasha L. Mason38 publicationsPeter S. Hendricks38 publicationsAlan K. Davis36 publicationsDavid Bryce Yaden35 publicationsMatthias E. Liechti34 publicationsChristopher Timmermann33 publicationsJohns Hopkins University33 publicationsMuhammad Ishrat Husain33 publicationsBrice Ozenne32 publicationsGuy M. Goodwin30 publicationsHannes Kettner30 publicationsRoger S. McIntyre30 publicationsDirk Hoffmeister29 publicationsJohannes G. Ramaekers29 publicationsMichael P. Bogenschutz29 publicationsStephen Ross29 publicationsErich Seifritz27 publicationsRobert B. Kargbo27 publicationsBrian Anderson26 publicationsXiaohui Wang26 publicationsCharles D. Nichols25 publicationsDrummond E-Wen McCulloch25 publicationsJavier González-Maeso25 publicationsMartin Korsbak Madsen25 publicationsRichard J. Zeifman25 publicationsAllan H. Young24 publicationsGabrielle Agin-Liebes24 publicationsMartin Kuchař24 publicationsMorten L. Kringelbach24 publicationsNathan D. Sepeda24 publicationsPaul Liknaitzky24 publicationsFriederike Holze23 publicationsNatalie Gukasyan23 publicationsRAFAEL GUIMARÃES DOS SANTOS23 publicationsGustavo Deco22 publicationsScott Aaronson22 publicationsAdam L. Halberstadt21 publicationsBrian S. Barnett21 publicationsBruna Giribaldi21 publicationsJacob S. Aday21 publicationsJaime E. C. Hallak21 publicationsManoj Doss21 publicationsOlivia Carter21 publicationsOtto Simonsson21 publicationsBenjamin Kelmendi20 publicationsJiřı́ Horáček20 publicationsMichael Kometer20 publicationsAlex Kwan19 publicationsBernard Lerer19 publicationsMatthew B. Wall19 publicationsRoland A. Fischer19 publicationsRotem Petranker19 publicationsCharles L. Raison18 publicationsDavid E. Nichols18 publicationsEnzo Tagliazucchi18 publicationsFelix Müller18 publicationsFilip Tylš18 publicationsMendel Kaelen18 publicationsRobert A. Schoevers18 publicationsAlexander M. Sherwood17 publicationsAmanda Feilding17 publicationsChristopher S. Stauffer17 publicationsDavid J. Hellerstein17 publicationsFernando Rosas17 publicationsJeffrey Guss17 publicationsMilan Scheidegger17 publicationsTomislav Majić17 publicationsWilliam A. Richards17 publicationsClaire J. Foldi16 publicationsGeyer MA16 publicationsJason B. Luoma16 publicationsKevin F. Boehnke16 publicationsLea J. Mertens16 publicationsMalievskaia E16 publicationsManish Agrawal16 publicationsNadav Liam Modlin16 publicationsSophia Armand16 publicationsYale University16 publicationsAnna M. Becker15 publicationsCharles S. Grob15 publicationsEmmanuelle A. D. Schindler15 publicationsFelix Hasler15 publicationsGerhard Gründer15 publicationsJennifer Jones15 publicationsJoshua S. Siegel15 publicationsKelly JR15 publicationsLindsey Marwood15 publicationsSuresh Muthukumaraswamy15 publicationsTzuri Lifschytz15 publicationsUniversity Hospital15 publicationsBoadie W. Dunlop14 publicationsBrandon Weiss14 publicationsChristopher Pittenger14 publicationsDanica E. Johnson14 publicationsFederico Seragnoli14 publicationsGregor Hasler14 publicationsHenrik Jungaberle14 publicationsJanis Fricke14 publicationsJeng-Yu Tsai14 publicationsJochen Gartz14 publicationsJosé Carlos Bouso14 publicationsMeg J Spriggs14 publications